InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Browse the detailed record of transactions filed by Bhatia Sangeeta N., Director. Director active across 2 companies, notably Vertex Pharmaceuticals INC / MA. Aggregated, 7 disclosures have been logged. Total volume traded: €107k. The latest transaction was disclosed on 2 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
€9,72140 shares@ €243.02840.0000% mcap3.0% of flow
Common Stock
SEC:0000899243-22-016638:0·
01,449 shares0
Common Stock
SEC:0000899243-22-016337:0·
€220,6471,907 shares@ €115.70350.0002% mcap67.3% of flow
Common Stock
SEC:0000899243-22-014549:0·
€48,775285 shares@ €171.1403100.0% of flow
Common Stock
SEC:0001209191-21-038182·
€48,775285 shares@ €171.14030.0000% mcap14.9% of flow
Common Stock
SEC:0001209191-21-038182:0·
01,842 shares0
Common Stock
SEC:0001209191-21-029837·
01,842 shares0
Common Stock
SEC:0001209191-21-029837:0·
7 of 7 declarations
About Bhatia Sangeeta N.
Sangeeta N. Bhatia serves as a Director at Vertex Pharmaceuticals Inc. In this role, she participates in the governance of the company and strategic decision-making. Her experience in the pharmaceutical sector is valuable for the organization's development.
